SIGN IN / REGISTER
(0) -
$
0.00
Menu
Home
Products
Providers
Education
Forms
Contact Us
Toggle Dropdown
by Item #
by Manufacturer #
by Brand
Home
/
Vaccines / Refrig Pharma
/ Nitro-Bid® Nitrate Nitroglycerin 2% Transdermal Ointment Foil Pack 1 Gram
Nitro-Bid® Nitrate Nitroglycerin 2% Transdermal Ointment Foil Pack 1 Gram
UOM CARTON/48
$
148.09
Features
48 foil packs
10000 in stock
Nitro-Bid® Nitrate Nitroglycerin 2% Transdermal Ointment Foil Pack 1 Gram quantity
Add to cart
Category:
Vaccines / Refrig Pharma
Description
Description
Item ID #
14538900
Manufacturer #
3282795
Brand
Nitro-Bid®
Features
48 foil packs
Related products
#19268900 Mfr# 0926476
HUMULIN NPH VL 100U/ML RX EA MCKESSON
Item ID # 19268900 Manufacturer # 0926476 Brand
UOM EACH/1
$55.656
Add to cart
#58908900 Mfr# 589-05
Menactra® Meningitis Vaccine Meningococcal (Groups A,C,Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine, Preservative Free 4 mcg / 0.5 mL Injection Single Dose Vial 0.5 mL
Features
Menactra is indicated for active immunization of individuals 2 through 55 years of age for the prevention of invasive meningococcal disease
Menactra vaccine is administered as a 0.5 mL dose by intramuscular injection
In children 9 through 23 months of age, Menactra is given as a 2-dose series three months apart
UOM CASE/5
$869.472
Add to cart
#30498901 Mfr# 00003029328
Kenalog®-40 Corticosteroid Triamcinolone Acetonide 40 mg / mL Intramuscular or Intra-articular Injection Vial 10 mL
Features
This drug should not be used in neonates
Not for intravenous, intradermal, intraocular, epidural, or intrathecal use
Kenalog®-40 Injection (triamcinolone acetonide injectable suspension, USP) is a synthetic glucocorticoid corticosteroid with anti-inflammatory action
UOM EACH/1
$125
Add to cart
#58908900 Mfr#
Menactra® Meningitis Vaccine Meningococcal (Groups A,C,Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine, Preservative Free 4 mcg / 0.5 mL Injection Single Dose Vial 0.5 mL
Features
Menactra is indicated for active immunization of individuals 2 through 55 years of age for the prevention of invasive meningococcal disease
Menactra vaccine is administered as a 0.5 mL dose by intramuscular injection
In children 9 through 23 months of age, Menactra is given as a 2-dose series three months apart
UOM CASE/5
$869.472
Add to cart